Met Life Investment Management, LLC Krystal Biotech, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 11,104 shares of KRYS stock, worth $2.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,104Holding current value
$2.04 Million% of portfolio
0.01%Shares
33 transactions
Others Institutions Holding KRYS
# of Institutions
262Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$469 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$447 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$332 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$277 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$182 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.71B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...